ArticleJournal for immunotherapy of cancer2025
Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxel.
Minu K Srivastava et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.